ZKIN to Attack all time high!
ZKIN, a pretty unknown stock as I would consider has made over 600% gains since my first bullish analysis at $2 per share, as now it's being trade above $12 per share!
ZKIN, a stock that has few days ago traded in Dollar value higher than:
- Walmart
- Starbucks
- McDonalds
- Ford Motors
- Coca Cola
- Twitter
and all major Covid vaccination companies!
Also, this company has currently gotten into NFT's recently as it's connected with blockchain.
From a technical perspective, the price action has formed an ascending triangle which has bias to break to the upside, potentially retesting the all time high at $16 per share!
MACD however is pretty overextended and is pointing towards a correction to 20 EMA to $10 before a move to bespoke resistance at $16.
The price can fall slightly below $9.00 without impacting the overall uptrend, where 50 EMA with uptrend line support are both located.
My outlook is bullish with no technical reason for a trend change!
Good luck!
ZKIN, a stock that has few days ago traded in Dollar value higher than:
- Walmart
- Starbucks
- McDonalds
- Ford Motors
- Coca Cola
and all major Covid vaccination companies!
Also, this company has currently gotten into NFT's recently as it's connected with blockchain.
From a technical perspective, the price action has formed an ascending triangle which has bias to break to the upside, potentially retesting the all time high at $16 per share!
MACD however is pretty overextended and is pointing towards a correction to 20 EMA to $10 before a move to bespoke resistance at $16.
The price can fall slightly below $9.00 without impacting the overall uptrend, where 50 EMA with uptrend line support are both located.
My outlook is bullish with no technical reason for a trend change!
Good luck!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.